Harvoni (ledipasvir / sofosbuvir) is a combination medication containing two antiviral medications, ledipasvir and sofosbuvir (Sovaldi). It is a first-choice treatment option for hepatitis C for certain types of people.
Harvoni (ledipasvir / sofosbuvir) contains 2 antiviral medications that work together to stop the hepatitis C virus from making copies of itself in the body.
The following side effects may get better over time as your body gets used to the medication. Let your healthcare provider know immediately if you continue to experience these symptoms or if they worsen over time.
Side effects that you should report to your care team as soon as possible:
Side effects that usually do not require medical attention (report to your care team if they continue or are bothersome):
Yes, a successful treatment with antivirals is considered a cure for heptitis C. In clinical trials, Harvoni (ledipasvir / sofosbuvir) cured 94% to 100% cases of hepatitis C genotype 1.
It's not likely that heptitis C will come back after achieving "SVR," which is considered a cure. However, treatment of hepatitis C doesn't make you immune to the virus, so it's possible to become reinfected. After treatment it's important to continue to protect yourself from hepatitis C and not receive unclean tattoos or share things like razors and needles.
Avoid alcohol while taking Harvoni (ledipasvir / sofosbuvir). It's not known if alcohol interacts with the medication, but alcohol and hepatitis C can both damage the liver.
In the U.S., Gilead makes branded Harvoni (ledipasvir / sofosbuvir). Asegua Therapeutics makes the authorized generic of Harvoni.
Both antiviral medications are very good at curing hepatitis C. Epclusa works for all genotypes of hepatitis C, while Harvoni (ledipasvir / sofosbuvir) works for 4 out of 6 types. Harvoni (ledipasvir / sofosbuvir) can cure hepatitic C in just 8 weeks for certain types of people; the shortest course of Epclusa is 12 weeks.
Harvoni (ledipasvir / sofosbuvir) can cause some serious health issues. This risk may be even higher for certain groups. If this worries you, talk to your doctor or pharmacist about other options.
Some people who have both hepatitis B and C have had their hepatitis B reactivate or flare up after starting treatment for hepatitic C. This can cause liver problems if not caught and treated. You should be tested for hepatitis B before you start Harvoni (ledipasvir / sofosbuvir). Tell your provider if you've ever had hepatitis B or been treated for it in the past.
There have been cases of slow heartbeat and fatal heart problems when people take amiodarone (Pacerone) and Harvoni (ledipasvir / sofosbuvir) together. It usually happens right after Harvoni (ledipasvir / sofosbuvir) is started, but can also happen weeks after the combination is taken. It's more likely to happen in people also taking beta blockers or with severe liver problems. Tell your provider if you are taking or have recently taken amiodarone. They may choose a different hepatitis C medication for you, or closely monitor your heartbeat. Go to the emergency room right away if you take these medications together and feel faint, dizzy, weak, or have trouble breathing.
People with certain types of liver problems may need to take an antiviral medication called ribavirin in addition to Harvoni (ledipasvir / sofosbuvir). Ribavirin can have a lot of side effects and should not be taken during pregnancy. Make sure to review this medication with your provider and pharmacist before starting your hepatitis C treatment.
| Dosage | Quantity | Price as low as | Price per unit |
|---|---|---|---|
| 90mg/400mg | 28 tablets | $11,526.26 | $411.65 |
Adults: 1 tablet once a day with or without food. The standard tablet contains 90 mg of ledipasvir and 400 mg of sofosbuvir.
Children: dose is based on the child's weight